Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toyoki Mori

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Life Sciences|March 28, 2006
Direct positive chronotropic action by angiotensin II in the isolated mouse atriumToyoki Mori, Ayako Hashimoto
Platelets|September 17, 2004
Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activationHideki Ito, Goro Miyakoda, Toyoki Mori
Pharmacology|January 15, 2005
Adrenal influences on the inhibitory effects of procaterol, a selective Beta-two-adrenoceptor agonist, on antigen-induced airway microvascular leakage and bronchoconstriction in Guinea pigsKatsumi Ikezono, Masayuki Kamata, Toyoki Mori
Journal of Immunological Methods|May 24, 2006
A novel modification of a flow cytometric assay of phosphorylated STAT1 in whole blood lymphocytes for rapid detection of interferon-alpha signal in vivoShiro Tochizawa, Yasukazu Ohmoto, Toyoki Mori
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 27, 2006
[Vasopressin receptors]Toyoki Mori, Shigeki Nakamura, Hiroyuki Fujiki
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 26, 2004
Nitric oxide (NO) is not involved in accentuated antagonism for chronotropy in the isolated mouse atriumToyoki Mori, Ayako Hashimoto, Hiromichi Takase, et al.
Atherosclerosis|March 21, 2006
Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanismAyako Hashimoto, Goro Miyakoda, Yoshimi Hirose, et al.
Cardiovascular Drug Reviews|April 21, 2007
Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trialsToshiki Miyazaki, Hiroyuki Fujiki, Yoshitaka Yamamura, et al.
Biochemical and Biophysical Research Communications|June 6, 2006
Functional expression of human type I interferon receptors in the mouse liverShiro Tochizawa, Masahiro Muraguchi, Yasukazu Ohmoto, et al.
International Archives of Allergy and Immunology|July 3, 2009
Procaterol potentiates the anti-inflammatory activity of budesonide on eosinophil adhesion to lung fibroblastsNorihiro Yoshida, Masahiro Muraguchi, Masayuki Kamata, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Life Sciences|March 28, 2006
Direct positive chronotropic action by angiotensin II in the isolated mouse atriumToyoki Mori, Ayako Hashimoto
Platelets|September 17, 2004
Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activationHideki Ito, Goro Miyakoda, Toyoki Mori
Pharmacology|January 15, 2005
Adrenal influences on the inhibitory effects of procaterol, a selective Beta-two-adrenoceptor agonist, on antigen-induced airway microvascular leakage and bronchoconstriction in Guinea pigsKatsumi Ikezono, Masayuki Kamata, Toyoki Mori
Journal of Immunological Methods|May 24, 2006
A novel modification of a flow cytometric assay of phosphorylated STAT1 in whole blood lymphocytes for rapid detection of interferon-alpha signal in vivoShiro Tochizawa, Yasukazu Ohmoto, Toyoki Mori
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 27, 2006
[Vasopressin receptors]Toyoki Mori, Shigeki Nakamura, Hiroyuki Fujiki
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 26, 2004
Nitric oxide (NO) is not involved in accentuated antagonism for chronotropy in the isolated mouse atriumToyoki Mori, Ayako Hashimoto, Hiromichi Takase, et al.
Atherosclerosis|March 21, 2006
Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanismAyako Hashimoto, Goro Miyakoda, Yoshimi Hirose, et al.
Cardiovascular Drug Reviews|April 21, 2007
Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trialsToshiki Miyazaki, Hiroyuki Fujiki, Yoshitaka Yamamura, et al.
Biochemical and Biophysical Research Communications|June 6, 2006
Functional expression of human type I interferon receptors in the mouse liverShiro Tochizawa, Masahiro Muraguchi, Yasukazu Ohmoto, et al.
International Archives of Allergy and Immunology|July 3, 2009
Procaterol potentiates the anti-inflammatory activity of budesonide on eosinophil adhesion to lung fibroblastsNorihiro Yoshida, Masahiro Muraguchi, Masayuki Kamata, et al.
Pageof 4